To the Editor The study by Birnbaum et al1 investigated infants’ antiepileptic drug (AED) exposure if mothers receiving AEDs were breastfeeding by comparing the percentage differences of mothers’ AED blood concentrations with their respective infants’ AED blood concentrations. For lamotrigine, infant-to-mother percentages had high variability between newborns, with concentrations ranging between 0.6% and 90.3%. Given that lamotrigine is likely a lipid-soluble medication,2 we wonder if infants with higher body fat composition (ie, infants who were large for gestational age), compared with the infants who were normal or small for gestational age, had a higher concentration of lamotrigine. If the blood concentration of lamotrigine in infants who were large for gestational age was significantly higher, the safety of breastfeeding in those infants should be evaluated more cautiously.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Hayes M, Puusepp-Benazzouz H. Exposure of Infants Who Are Breastfed to Antiepileptic Drugs. JAMA Neurol. 2020;77(12):1577–1578. doi:10.1001/jamaneurol.2020.3030
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: